Citius Pharmaceuticals, Inc. announced that it has appointed Mr. Myron Holubiak to the board of directors effective October 1, 2015. Mr. Holubiak has extensive experience in managing and advising both large and emerging pharmaceutical and life sciences companies. He is the former President of Roche Laboratories, Inc. a position he held from December 1998 to August 2001.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.6513 USD | -2.12% | +2.86% | -14.08% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.08% | 120M | |
+45.20% | 56.65B | |
-7.13% | 39.44B | |
+39.19% | 39.03B | |
-11.17% | 26.86B | |
+12.37% | 26.75B | |
-21.71% | 19.03B | |
+1.41% | 12.28B | |
+23.96% | 12.26B | |
+27.13% | 12.04B |
- Stock Market
- Equities
- CTXR Stock
- News Citius Pharmaceuticals, Inc.
- Citius Pharmaceuticals, Inc. Appoints Mr. Myron Holubiak to Board of Directors